Install
Empowering Investor Success Morningstar Morningstar is an investment research company offering mutual fund, ETF, and stock analysis, ratings, and data, and portfolio tools. Discover actionable insights today. Plus, whether Nvidia is a buy after earnings.
- 1,392articles · 30d
- 5+ hour agolatest article
- Aug 14, 2026earliest in window
- 88%with images · 6 videos
- 240avg words
- economy business and finance 753
- FIB 735
- NW 418
- BI 157
- FI 152
- crime law and justice 120
- HW 117
- arts culture entertainment and media 115
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
HDFC Bank Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against HDFC Bank Limited - HDB
3+ week, 1+ day ago (301+ words) Morningstar HDFC Bank Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against HDFC Bank Limited - HDB PR Newswire NEW ORLEANS, Aug 21, 2026 NEW ORLEANS, Aug 21, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information…...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in The Simply Good Foods Company Lawsuit - SMPL
3+ day, 13+ hour ago (646+ words) filings, made public statements, or certified financial disclosures under Sarbanes-Oxley. Q: What specific...
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 29, 2026 in Pentwater Capital Management LP Lawsuit - CAR
2+ day, 15+ hour ago (716+ words) NEW YORK, Sept. 10, 2026 A securities class action alleges that Pentwater Capital Management LP and its CEO drove Avis Budget Group shares up more than 400% before dumping 4.3 million shares over two trading days, and this release maps the sequence of dated…...
Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
3+ day, 15+ hour ago (518+ words) between August 1, 2025 and May 15, 2026 and suffered financial losses may be eligible. Eligibility is based...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 21, 2026 in COGENT COMMUNICATIONS HOLDINGS, INC. Lawsuit - CCOI
1+ week, 3+ day ago (647+ words) February 29, 2024 and May 1, 2026 and suffered financial losses may be eligible. Eligibility is based...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
1+ mon, 6+ day ago (375+ words) 2025, and July 26, 2026, and suffered significant financial losses, you have until September 28, 2026, to...
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Peabody Energy Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
2+ week, 5+ day ago (299+ words) Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Peabody Energy To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Peabody Energy between October 14, 2024 and May 4, 2026 and would…...
XTIA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds XTI Aerospace Investors of Securities Class Action Lawsuit Deadline on October 27, 2026
1+ week, 5+ day ago (296+ words) Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in XTI Aerospace to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in XTI Aerospace between April 15, 2026 and August 17, 2026 and would…...
REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt
3+ week, 2+ day ago (684+ words) NEW YORK, Aug. 20, 2026 This Regeneron analyst reaction focuses on analysts' reassessment of the Phase III Fianlimab-Libtayo Study after a protocol amendment raised concerns about statistical significance and potential impact on Regeneron's pipeline and future growth expectations. NEW YORK, Aug. 20, 2026 /PRNewswire…...
AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
2+ day, 13+ hour ago (572+ words) NEW YORK, Sept. 10, 2026 Sections 11 and 15 of the Securities Act impose liability for registration statements containing untrue statements of material fact. A securities class action alleges Aardvark Therapeutics' IPO paperwork described ARD-101 as "99% restricted to the gut" with "no serious adverse…...